Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Influenza

  Free Subscription


Articles published in Am J Med

Retrieve available abstracts of 79 articles:
HTML format



Single Articles


    February 2026
  1. CHENG Y, Ling Y, Scholten J, Atkins D, et al
    Patterns and trends in prevalent central nervous system stimulant use in US veterans with traumatic brain injury.
    Am J Med. 2026;139:170-180.
    PubMed     Abstract available


    October 2025
  2. WAHID L, Kwon T, Kreuziger LB, Kasthuri RS, et al
    Extended Thromboprophylaxis in Patients Hospitalized with COVID-19 at Time of Discharge is Not Associated with Improvement in Quality of Life.
    Am J Med. 2025;138:1464-1468.
    PubMed     Abstract available


    June 2025
  3. STAHLBERG M, Fischer K, Tahhan M, Zhao A, et al
    Post-Acute COVID-19 Syndrome: Prevalence of Peripheral Microvascular Endothelial Dysfunction and Associations With NT-ProBNP Dynamics.
    Am J Med. 2025;138:1019-1028.
    PubMed     Abstract available


  4. ZHOU T, Sawano M, Arun AS, Caraballo C, et al
    Internal Tremors and Vibrations in Long COVID: A Cross-Sectional Study.
    Am J Med. 2025;138:1010-1018.
    PubMed     Abstract available


  5. SANAL-HAYES NEM, Mclaughlin M, Hayes LD, Berry ECJ, et al
    Examining Well-Being and Cognitive Function in People With Long COVID and ME/CFS, and Age-Matched Healthy Controls: A Case-Case-Control Study.
    Am J Med. 2025;138:1029-1037.
    PubMed     Abstract available


    May 2025
  6. BILC M, Cramer H
    Use of Complementary Medicine Among US Adults with Post-COVID-19: Results from the 2022 National Health Interview Survey.
    Am J Med. 2025;138:862-869.
    PubMed     Abstract available


  7. MAURO M, Cegolon L, Bestiaco N, Zulian E, et al
    Heart Rate Variability Modulation Through Slow-Paced Breathing in Health Care Workers with Long COVID: A Case-Control Study.
    Am J Med. 2025;138:870-883.
    PubMed     Abstract available


  8. NAIK H, Wilton J, Tran KC, Janjua NZ, et al
    Long-Term Health-Related Quality of Life in Working-Age COVID-19 Survivors: A Cross-Sectional Study.
    Am J Med. 2025;138:850-861.
    PubMed     Abstract available


  9. PALACIO A, Bast E, Klimas N, Tamariz L, et al
    Lessons Learned in Implementing a Multidisciplinary Long COVID Clinic.
    Am J Med. 2025;138:843-849.
    PubMed     Abstract available


  10. SANAL-HAYES NEM, Hayes LD, Mclaughlin M, Berry ECJ, et al
    People with Long COVID and ME/CFS Exhibit Similarly Impaired Dexterity and Bimanual Coordination: A Case-Case-Control Study.
    Am J Med. 2025;138:893-900.
    PubMed     Abstract available


    April 2025
  11. HOLLAND J, Sheehan D, Brown S, O'Flanagan S, et al
    Immune Response and Cognitive Impairment in Post-COVID Syndrome: A Systematic Review.
    Am J Med. 2025;138:698-711.
    PubMed     Abstract available


  12. XU J, Wu D, Yang J, Zhao Y, et al
    Adult Outpatients with Long COVID Infected with SARS-CoV-2 Omicron Variant. Part 1: Oral Microbiota Alterations.
    Am J Med. 2025;138:732-741.
    PubMed     Abstract available


  13. YOO KH, Lee SH, Cho Y, Kim YJ, et al
    Synergistic Effect of SARS-CoV-2 Infection and COVID-19 Vaccination on the Risk of Venous Thromboembolism.
    Am J Med. 2025;138:673-680.
    PubMed     Abstract available


  14. MARKSER A, Vockel J, Schneider A, Baumeister-Lingens L, et al
    Non-Invasive Brain Stimulation for Post-COVID-19 Conditions: A Systematic Review.
    Am J Med. 2025;138:681-697.
    PubMed     Abstract available


  15. SAWANO M, Wu Y, Shah RM, Zhou T, et al
    Long COVID Characteristics and Experience: A Descriptive Study From the Yale LISTEN Research Cohort.
    Am J Med. 2025;138:712-720.
    PubMed     Abstract available


  16. SANAL-HAYES NEM, Hayes LD, Mclaughlin M, Berry ECJ, et al
    Post-Traumatic Stress Disorder and Complex Post-Traumatic Stress Disorder in People with Long COVID, ME/CFS, and Controls.
    Am J Med. 2025;138:742-749.
    PubMed     Abstract available


    March 2025
  17. PAN D, Diaz JL, Weidman K, Graham J, et al
    Social Networks as a Key Health Determinant in Acute Illness Recovery: A Lesson from the COVID-19 Pandemic.
    Am J Med. 2025;138:541-549.
    PubMed     Abstract available


  18. BENITO-LEON J, Lapena J, Garcia-Vasco L, Cuevas C, et al
    Exploring Cognitive Dysfunction in Long COVID Patients: Eye Movement Abnormalities and Frontal-Subcortical Circuits Implications via Eye-Tracking and Machine Learning.
    Am J Med. 2025;138:550-559.
    PubMed     Abstract available


  19. HEJAZIAN SS, Sadr AV, Shahjouei S, Vemuri A, et al
    Prevalence and Determinants of Long-Term Post-COVID Conditions in the United States: 2022 Behavioral Risk Factor Surveillance System.
    Am J Med. 2025;138:513-523.
    PubMed     Abstract available


  20. MCLAUGHLIN M, Sanal-Hayes NEM, Hayes LD, Berry EC, et al
    People with Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Exhibit Similarly Impaired Vascular Function.
    Am J Med. 2025;138:560-566.
    PubMed     Abstract available


    February 2025
  21. ULVI SAYGI AYVACI M, Jacobi VS, Ryu Y, Gundreddy SPS, et al
    Clinically Guided Adaptive Machine Learning Update Strategies for Predicting Severe COVID-19 Outcomes.
    Am J Med. 2025;138:228-235.
    PubMed     Abstract available


  22. DUNN J, Davis BR, Matarazzo A, Willett Y, et al
    New Clinical and Public Health Challenges in Vaccinations in US Adults.
    Am J Med. 2025;138:185-189.
    PubMed     Abstract available


  23. PALAU P, Calvo B, Sastre C, Dominguez E, et al
    Unraveling the Mechanisms Behind Exercise Intolerance and Recovery in Long COVID.
    Am J Med. 2025;138:362-367.
    PubMed     Abstract available


  24. BONNER-JACKSON A, Vangal R, Li Y, Thompson N, et al
    Factors Associated with Cognitive Impairment in Patients with Persisting Sequelae of COVID-19.
    Am J Med. 2025;138:337-345.
    PubMed     Abstract available


  25. LEE JS, Choi Y, Joung JY, Son CG, et al
    Clinical and Laboratory Characteristics of Fatigue-Dominant Long-COVID Subjects: A Cross-Sectional Study.
    Am J Med. 2025;138:346-353.
    PubMed     Abstract available


  26. ZHENG C, Huang WY, Sun FH, Wong MC, et al
    Association of Sedentary Lifestyle with Risk of Acute and Post-Acute COVID-19 Sequelae: A Retrospective Cohort Study.
    Am J Med. 2025;138:298-307.
    PubMed     Abstract available


  27. LAU B, Wentz E, Ni Z, Yenokyan K, et al
    Physical Health and Mental Fatigue Disability Associated with Long COVID: Baseline Results from a US Nationwide Cohort.
    Am J Med. 2025;138:287-297.
    PubMed     Abstract available


  28. MCLAUGHLIN M, Cerexhe L, Macdonald E, Ingram J, et al
    A Cross-Sectional Study of Symptom Prevalence, Frequency, Severity, and Impact of Long COVID in Scotland: Part II.
    Am J Med. 2025;138:330-336.
    PubMed     Abstract available


  29. SEELEY MC, Gallagher C, Ong E, Langdon A, et al
    High Incidence of Autonomic Dysfunction and Postural Orthostatic Tachycardia Syndrome in Patients with Long COVID: Implications for Management and Health Care Planning.
    Am J Med. 2025;138:354-361.
    PubMed     Abstract available


    January 2025
  30. LIPPI G, Sanchis-Gomar F, Lavie CJ
    The recent (2018-2022) US monthly mortality for acute myocardial infarction still peaks in December and January.
    Am J Med. 2025 Jan 18:S0002-9343(25)00035-X. doi: 10.1016/j.amjmed.2025.
    PubMed     Abstract available


  31. HAWLEY HB
    Long COVID: Clinical Findings, Pathology, and Endothelial Molecular Mechanisms.
    Am J Med. 2025;138:91-97.
    PubMed     Abstract available


  32. HAYES LD, Sanal-Hayes NEM, Mclaughlin M, Berry ECJ, et al
    People with Long Covid and ME/CFS Exhibit Similarly Impaired Balance and Physical Capacity: A Case-Case-Control Study.
    Am J Med. 2025;138:140-147.
    PubMed     Abstract available


  33. MCLAUGHLIN M, Cerexhe L, Macdonald E, Ingram J, et al
    A Cross-Sectional Study of Symptom Prevalence, Frequency, Severity, and Impact of Long COVID in Scotland: Part I.
    Am J Med. 2025;138:121-130.
    PubMed     Abstract available


  34. HONDA H, Takamatsu A, Miwa T, Tabuchi T, et al
    Prolonged Symptoms after COVID-19 in Japan: A Nationwide Survey of the Symptoms and Their Impact on Patients' Quality of Life.
    Am J Med. 2025;138:98-107.
    PubMed     Abstract available


  35. BAILEY J, Lavelle B, Miller J, Jimenez M, et al
    Multidisciplinary Center Care for Long COVID Syndrome-A Retrospective Cohort Study.
    Am J Med. 2025;138:108-120.
    PubMed     Abstract available


  36. XUEREB RA, Borg M, Vella K, Gatt A, et al
    Long COVID Syndrome: A Case-Control Study.
    Am J Med. 2025;138:131-139.
    PubMed     Abstract available


  37. HASLAM A, Prasad V
    Comparability of Control and Comparison Groups in Studies Assessing Long COVID.
    Am J Med. 2025;138:148-152.
    PubMed     Abstract available


    December 2024
  38. ISMAIL A, Shadid HR, Huang Y, Hutten CG, et al
    Statin Therapy, Inflammation, and Outcomes in Patients Hospitalized for COVID-19: A Prospective Multicenter Cohort Study.
    Am J Med. 2024;137:1264-1271.
    PubMed     Abstract available


  39. KENNEDY BS, Richeson RP, Houde AJ
    Justice-Involved Status and In-Hospital Mortality Among Nonelderly Adults During the COVID-19 Pandemic, 2021.
    Am J Med. 2024;137:1216-1226.
    PubMed     Abstract available


    October 2024
  40. BEAUCHAMP M, Kirkwood R, Duong M, Ho T, et al
    Long-Term Functional Limitations and Predictors of Recovery After COVID-19: A Multicenter Prospective Cohort Study.
    Am J Med. 2024;137:990-1000.
    PubMed     Abstract available


  41. FLORENCIO DE MESQUITA C, Rivera A, Araujo B, Duraes VL, et al
    Adjunctive Statin Therapy in Patients with Covid-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Am J Med. 2024;137:966-973.
    PubMed     Abstract available


    September 2024
  42. SCHATTNER A
    Unexpected Morbidity following Influenza in older people: Implications for Vaccination.
    Am J Med. 2024 Sep 18:S0002-9343(24)00579-5. doi: 10.1016/j.amjmed.2024.
    PubMed    


  43. PASCULLI P, Zingaropoli MA, Dominelli F, Solimini AG, et al
    Insights into Long COVID: Unraveling Risk Factors, Clinical Features, Radiological Findings, Functional Sequelae and Correlations: A Retrospective Cohort Study.
    Am J Med. 2024 Sep 17:S0002-9343(24)00569-2. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  44. DAUNGSUPAWONG H, Wiwanitkit V
    Nirmatrelvir/Ritonavir Compared With Placebo/Ritonavir for Long COVID: A Comment.
    Am J Med. 2024;137:e173.
    PubMed    


  45. SHAH KM, Shah RM, Sawano M, Wu Y, et al
    Factors Associated with Long COVID Recovery among US Adults.
    Am J Med. 2024;137:896-899.
    PubMed     Abstract available


    August 2024
  46. FINSTERER J
    A Relapse of Restless Leg Syndrome Due to COVID-19 Can Only Be Diagnosed If Other Explanations Are Ruled Out.
    Am J Med. 2024;137:e159.
    PubMed    


    July 2024
  47. ZHAI L, Gong H, Yu W
    New Insights on Obstructive Sleep Apnea and Postacute Sequelae of SARS-CoV-2 Infection.
    Am J Med. 2024;137:e139.
    PubMed    


  48. ALAEDINI A, Lightman S, Wormser GP
    Is Low Cortisol a Marker of Long COVID?
    Am J Med. 2024;137:564-565.
    PubMed    


    June 2024
  49. COLLAMORE G, DiCorcia MJ, Nagpal Y, Fiedler L, et al
    Guidance for Healthcare Providers on Newest Guidelines for Over-the-Counter Drug Treatment of Mild Symptoms of COVID-19.
    Am J Med. 2024;137:490-493.
    PubMed     Abstract available


  50. WU Y, Sawano M, Wu Y, Shah RM, et al
    Factors Associated With Long COVID: Insights From Two Nationwide Surveys.
    Am J Med. 2024;137:515-519.
    PubMed     Abstract available


  51. TAN BJ, Lo YL, Chan LL, Tan EK, et al
    Re-Emergence of Childhood Restless Legs Syndrome in Adulthood Following COVID-19 Infection.
    Am J Med. 2024;137:e109-e110.
    PubMed    


  52. WINGO MT, Andersen CA, Bornstein SL, Huber JM, et al
    Update in Outpatient General Internal Medicine: Practice-Changing Evidence Published in 2023.
    Am J Med. 2024;137:494-499.
    PubMed     Abstract available


  53. QUAN SF, Weaver MD, Czeisler ME, Barger LK, et al
    Association of Obstructive Sleep Apnea with Post-Acute Sequelae of SARS-CoV-2 Infection.
    Am J Med. 2024;137:529-537.
    PubMed     Abstract available


    May 2024
  54. KRUMHOLZ HM, Sawano M, Bhattacharjee B, Caraballo C, et al
    The PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-blind Study of Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir for Long COVID.
    Am J Med. 2024 May 10:S0002-9343(24)00271-7. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


    April 2024
  55. VELASQUEZ GARCIA HA, Wong S, Jeong D, Binka M, et al
    Risk of major adverse cardiovascular events after SARS-CoV-2 infection in British Columbia: a population-based study.
    Am J Med. 2024 Apr 24:S0002-9343(24)00237-7. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  56. THAPALIYA K, Marshall-Gradisnik S, Eaton-Fitch N, Eftekhari Z, et al
    Imbalanced Brain Neurochemicals in long COVID and ME/CFS: A Preliminary Study using MRI.
    Am J Med. 2024 Apr 6:S0002-9343(24)00216-X. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  57. KOW CS, Ramachandram DS, Hasan SS, Thiruchelvam K, et al
    Navigating the Shadows: COVID-19's Lingering Threat - Pulmonary Fibrosis.
    Am J Med. 2024;137:e81.
    PubMed    


    March 2024
  58. HOWICK V JF, Saric P, Elwazir M, Newman DB, et al
    A Pragmatic Study of Cardiovascular Disease During Long-Term COVID-19.
    Am J Med. 2024 Mar 26:S0002-9343(24)00162-1. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  59. ASHIQUE S, Mishra N, Garg A, Garg S, et al
    A Critical Review on the Long-term COVID-19 Impacts on Patients with Diabetes.
    Am J Med. 2024 Mar 12:S0002-9343(24)00133-5. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  60. WONG RJ, Yang Z, Ostacher M, Zhang W, et al
    Alcohol Use Patterns During and After the COVID-19 Pandemic Among Veterans in the United States.
    Am J Med. 2024;137:236-239.
    PubMed     Abstract available


  61. REDELMEIER DA, Wang J, Drover SSM
    COVID Vaccine Hesitancy and Long-Term Traffic Risks.
    Am J Med. 2024;137:227-235.
    PubMed     Abstract available


    February 2024
  62. HAMMOND MM, Cameron NA, Shah NS, Khan SS, et al
    An Age-Period-Cohort Analysis of Cardiovascular Disease Mortality in the United States from 1999 to 2018.
    Am J Med. 2024 Feb 22:S0002-9343(24)00108-6. doi: 10.1016/j.amjmed.2024.
    PubMed     Abstract available


  63. WOOD SK, Maki DG, Glickman M, Hennekens CH, et al
    Guidance for Health Care Providers on the Newest COVID-19 Vaccine.
    Am J Med. 2024;137:79-80.
    PubMed    


    January 2024
  64. LU A, Chen CC, Lin C, Wu TJ, et al
    Artificial Intelligence Electrocardiography Detecting Thyrotoxic Periodic Paralysis Following a SARS-CoV-2 Infection.
    Am J Med. 2024 Jan 25:S0002-9343(24)00054-8. doi: 10.1016/j.amjmed.2024.
    PubMed    


    December 2023
  65. BAKER JB, Ghatak A, Cullen MR, Horwitz RI, et al
    Development of a Novel Clinical Risk Score for COVID-19 Infections.
    Am J Med. 2023;136:1169-1178.
    PubMed     Abstract available


    November 2023
  66. RIST PM, Buring JE, Manson JE, Sesso HD, et al
    History of Migraine and Risk of COVID-19: A Cohort Study.
    Am J Med. 2023;136:1094-1098.
    PubMed     Abstract available


  67. NAJJAR-DEBBINY R, Barnett-Griness O, Khoury J, Gronich N, et al
    Association Between COVID-19 Infection and Pulmonary Fibrosis: A Nested Case-Control Study.
    Am J Med. 2023;136:1087-1093.
    PubMed     Abstract available


    October 2023
  68. GRAHAM DJ, Izurieta HS, Zhang D, Avagyan A, et al
    Risk of Severe COVID-19 in Prevalent Users of Alpha-1 Adrenergic Receptor Antagonists: A National Case-Control Study of Medicare Beneficiaries.
    Am J Med. 2023;136:1018-1025.
    PubMed     Abstract available


  69. BRYAN NS, Molnar J, Somberg J
    The Efficacy of Nitric Oxide-Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patients of African American and Hispanic Origin.
    Am J Med. 2023;136:1035-1040.
    PubMed     Abstract available


    September 2023
  70. ADEPOJU VA, Imoyera W
    Addressing COVID Vaccine Hesitancy and Its Impact on Road Crashes.
    Am J Med. 2023;136:e179.
    PubMed    


  71. HUBER JM, Wieland ML, Bornstein SL, Mauck KF, et al
    Update in Outpatient General Internal Medicine: Practice-Changing Evidence Published in 2022.
    Am J Med. 2023;136:869-873.
    PubMed     Abstract available


    August 2023
  72. QUAN SF, Weaver MD, Czeisler ME, Barger LK, et al
    Insomnia, Poor Sleep Quality and Sleep Duration, and Risk for COVID-19 Infection and Hospitalization.
    Am J Med. 2023;136:780-788.
    PubMed     Abstract available


  73. GOETZL EJ, Yao PJ, Kapogiannis D
    Prediction of Post-Acute-Sequelae of COVID-19 by Cargo Protein Biomarkers of Blood Total Extracellular Vesicles in Acute COVID-19.
    Am J Med. 2023;136:824-829.
    PubMed     Abstract available


    July 2023
  74. SCHABAS R, Grant J, Fulford M, Rau N, et al
    Comments on COVID Vaccine Hesitancy and Traffic Crash Risk.
    Am J Med. 2023;136:e146.
    PubMed    


    June 2023
  75. AMRAOTKAR AR, Keith RJ, Palmer KE, Bhatnagar A, et al
    Using SARS-CoV-2 Antibody Testing in COVID-19 Research.
    Am J Med. 2023;136:501-503.
    PubMed    


  76. MA W, Murray E, Nguyen LH, Drew DA, et al
    Physical Activity, Sedentary Behavior, and Risk of Coronavirus Disease 2019.
    Am J Med. 2023;136:568-576.
    PubMed     Abstract available


    May 2023
  77. MUNGMUNPUNTIPANTIP R, Wiwanitkit V
    Comments on COVID Vaccine Hesitancy and Traffic Crashes.
    Am J Med. 2023;136:e100.
    PubMed    


  78. ARENA R
    Use of the Healthy Living Medicine Platform to Minimize COVID-19 Vaccination: Dispelling This Myth Before It Takes Hold.
    Am J Med. 2023;136:403-404.
    PubMed    


    March 2023
  79. AL-OBAIDI MM, Gungor AB, Murugapandian S, Thajudeen B, et al
    The Impact of Nirmatrelvir-Ritonavir in Reducing Hospitalizations Among High-Risk Patients with SARS-Cov-2 During the Omicron Predominant Era.
    Am J Med. 2023 Mar 8:S0002-9343(23)00145-6. doi: 10.1016/j.amjmed.2023.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum